Growth Disrupted in One-Third of JIA Patients, Study
Overview
A study found that approximately one in three children with juvenile idiopathic arthritis (JIA) experience growth or pubertal disturbances. The research highlights the need for ongoing monitoring of growth and sexual development in these patients.
Background
Juvenile idiopathic arthritis (JIA) is the most prevalent rheumatic disorder in children, with significant implications for growth and development. Inadequately managed JIA can lead to chronic pain, irreversible joint deformities, and a decline in functional capacity. Understanding the impact of JIA on growth and hormonal regulation is essential for improving patient outcomes.
Data Highlights
| Finding | Percentage |
|---|---|
| Shorter than expected for age | 20.6% |
| Underweight | 22.4% |
| Low body mass index (BMI) | 25.2% |
| Delayed puberty or menarche | 2.8% |
Key Findings
- 20.6% of children were shorter than expected for their age.
- 22.4% were underweight, correlating with longer disease duration.
- 25.2% had a low body mass index (BMI), associated with higher disease activity.
- Only 2.8% experienced delayed puberty or menarche.
- Most children had age-appropriate pubertal development despite hormonal abnormalities.
Clinical Implications
Healthcare providers should monitor growth and hormonal levels in children with JIA, especially those with early-onset or long-standing disease.
Conclusion
The study emphasizes the importance of ongoing evaluation of growth and development in children with JIA.
Related Resources & Content
- Mukherjee S, Pediatric Rheumatology, 2023 -- Growth Disrupted in One-Third of JIA Patients, Study
- Arthritis Care & Research — Cumulative Social Disadvantage and Disease Activity in Juvenile Idiopathic Arthritis: A Childhood Arthritis and Rheumatology Research Alliance Registry Study
- Frontiers in Pediatrics — Therapeutic efficacy of upadacitinib in refractory juvenile idiopathic arthritis: a case report
- Clinical Rheumatology — Assessment of ILAR and PRINTO Criteria for Juvenile Idiopathic Arthritis: Comparing Oligoarticular JIA with Early-Onset ANA-Positive JIA
- conexiant — Fatigue, Pain May Be Tied to Disability in JIA
- Cumulative Social Disadvantage and Disease Activity in Juvenile Idiopathic Arthritis
- Therapeutic efficacy of upadacitinib in refractory juvenile idiopathic arthritis
- Assessment of ILAR and PRINTO Criteria for Juvenile Idiopathic Arthritis
- https://assets.contentstack.io/v3/assets/bltee37abb6b278ab2c/blt4e307b8933591fa5/jia-guidelines-summary-2026.pdf
- EULAR/PReS recommendations for the diagnosis and management of Still's disease, comprising systemic juvenile idiopathic arthritis and adult-onset Still's disease - PubMed
- Endocrine dysfunction in patients with juvenile idiopathic arthritis | Pediatric Rheumatology | Springer Nature Link
- Annals of the Rheumatic Diseases | Vol 83, Suppl 1, Pages 1-2244 (June 2024) | ScienceDirect.com by Elsevier
- RESEARCH ARTICLE
- The impact of BMI on disease activity and growth outcomes in juvenile idiopathic arthritis | European Journal of Pediatrics | Springer Nature Link
- Bone health in juvenile idiopathic arthritis compared with controls based on a Norwegian observational study | RMD Open
- Early intensification versus step-up biologic strategies in systemic juvenile idiopathic arthritis: a Bayesian network meta-analysis of remission and safety outcomes | Pediatric Rheumatology | Springer Nature Link
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.
